標(biāo)題: Titlebook: Cancer Policy: Pharmaceutical Safety; June M. McKoy,Dennis P. West Book 2019 Springer Nature Switzerland AG 2019 Drug Safety.Health.Oncolo [打印本頁] 作者: 從未迷惑 時間: 2025-3-21 19:27
書目名稱Cancer Policy: Pharmaceutical Safety影響因子(影響力)
作者: 賞錢 時間: 2025-3-21 22:04
New Documentaries in Latin AmericaThis Chapter provides an introduction and overview of the U.S. FDA REMS program and applicable regulatory aspects. Topics covered include the 2015 Draft Guidance, organization structure and functions, a discussion on pharmacovigilance and adverse event reports, and a discussion of the applicability of REMS in oncology.作者: 交響樂 時間: 2025-3-22 02:48 作者: 特征 時間: 2025-3-22 06:56 作者: NICHE 時間: 2025-3-22 12:40 作者: BIPED 時間: 2025-3-22 15:31
June M. McKoy,Dennis P. WestDescribes the latest thoughts and findings relating to drug safety in the cancer domain.Covers emerging strategies to identify adverse drug reactions and drug-drug interactions.Highlights policies ins作者: BIPED 時間: 2025-3-22 17:33 作者: paleolithic 時間: 2025-3-22 22:04 作者: engender 時間: 2025-3-23 02:47
Essay 2: Environmental Performance,ic concerns drive drug safety improvements. This chapter examines pressures on drug costs due to the complexity of care and drug therapies, marked structure in which care is provided, and regulatory requirements driving safety.作者: ineffectual 時間: 2025-3-23 07:53 作者: Factorable 時間: 2025-3-23 13:05
Appendix: Axioms of Production,rapies, specifically herbal supplements, has become of increasing importance in the oncologic setting. This chapter focuses on the pharmacovigilance of herbal supplements in the setting of cancer drug therapy and explores national and international drug policies that have been employed to mitigate a作者: 窗簾等 時間: 2025-3-23 16:58
Current Topics in Behavioral Neurosciencesn, particularly for cancer patients. If counted as a separate cause of death, adverse drug reactions would represent the fourth leading cause of death in the United States. Several legal strategies are available to help mitigate their occurrences and to compensate victims for the harm that results f作者: attenuate 時間: 2025-3-23 19:11 作者: 天文臺 時間: 2025-3-24 01:55 作者: evaculate 時間: 2025-3-24 03:42 作者: 外形 時間: 2025-3-24 10:11 作者: Original 時間: 2025-3-24 10:43
https://doi.org/10.1007/978-3-319-43896-2Drug Safety; Health; Oncology; Pharmaceutical; Policy; Toxicity作者: Gastric 時間: 2025-3-24 16:54 作者: Decibel 時間: 2025-3-24 21:13
New Documentaries in Latin Americaeen contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.作者: 敏捷 時間: 2025-3-25 02:09
Book 2019derstanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural langua作者: 粗野 時間: 2025-3-25 06:54
Book 2019ging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.作者: Painstaking 時間: 2025-3-25 08:56 作者: figure 時間: 2025-3-25 13:19
Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos,ictive analytics, and other emerging drug therapies. It will use expansive patient registries and increase early access to clinical trials. The initiative is cocooned in forward-thinking drug policies that consider the specific needs of all oncology stakeholder groups both nationally and internationally.作者: Circumscribe 時間: 2025-3-25 17:28 作者: 他去就結(jié)束 時間: 2025-3-25 23:08
New Discoveries on the β-Hydride Eliminationoperties of biosimilars that merit attention in terms of optimizing their safety, delivering on appropriate related cost savings, and ensuring that appropriate premiums on innovative research are available to ensure ongoing progress in anticancer therapy.作者: BOOM 時間: 2025-3-26 01:16 作者: brother 時間: 2025-3-26 05:50
Cancer Drug Toxicity: Moving from Patient to Survivor,een contributed to increasing longevity. Of note, all cancer types have benefited in the survivorship arena. The advent of expansive survivorship care planning mandated by national governmental agencies and the emergence of newer classes of drug therapies for cancer are expected to buttress and support cancer survivorship in the coming decades.作者: 步履蹣跚 時間: 2025-3-26 11:18
Pharmacovigilance of Alternative Medications in the Cancer Setting,e AHEs in the cancer setting. The safety of herbal medicines has emerged as an international public health priority, and we explore how oncology providers may directly apply the knowledge garnered herein to help guide their clinical management of oncology patients utilizing alternative medications.作者: 愛國者 時間: 2025-3-26 14:12
Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies,e electronic health records. For victims of adverse drug reactions, tort lawsuits filed in the courts help compensate for the harm suffered and may also serve as warnings to manufacturers to improve drug safety to avoid future legal liability. While encouraging developments have occurred, new and ex作者: insomnia 時間: 2025-3-26 19:59 作者: 大暴雨 時間: 2025-3-26 21:11 作者: 外向者 時間: 2025-3-27 02:41 作者: 極肥胖 時間: 2025-3-27 06:35
Current Topics in Behavioral Neurosciencese electronic health records. For victims of adverse drug reactions, tort lawsuits filed in the courts help compensate for the harm suffered and may also serve as warnings to manufacturers to improve drug safety to avoid future legal liability. While encouraging developments have occurred, new and ex作者: 地名表 時間: 2025-3-27 09:44
New Discoveries on the β-Hydride Eliminationerfeit products that compromise patient safety. The Food and Drug Administration plays a key role in preventing and managing pharmaceutical shortages, largely through regulations requiring early notification of manufacturing interruptions. Other proposed strategies similarly target upstream causes a作者: 正式通知 時間: 2025-3-27 16:18 作者: 單調(diào)女 時間: 2025-3-27 20:49 作者: 陳舊 時間: 2025-3-27 22:24
Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies,n, particularly for cancer patients. If counted as a separate cause of death, adverse drug reactions would represent the fourth leading cause of death in the United States. Several legal strategies are available to help mitigate their occurrences and to compensate victims for the harm that results f作者: CRUMB 時間: 2025-3-28 03:13 作者: BRIDE 時間: 2025-3-28 08:50
The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety,s safety risks for patients and substantial burden on providers and the healthcare system. Multifaceted drivers of this complex problem include manufacturing disruptions, raw material shortages, regulatory issues, market dynamics, and limited financial incentives that reward quality and production o作者: 薄膜 時間: 2025-3-28 11:19 作者: –FER 時間: 2025-3-28 16:55 作者: 供過于求 時間: 2025-3-28 21:05
